Hepatitis C- and Human Immunodeficiency Virus-Induced Hypersensitivity Vasculitis

Sene D Ghillani-Dalbin P Thibault V Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus J. Rheumatol. 200431 2199–2206

Vallat L Benhamou Y Gutierrez M Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection Arthritis Rheum. 200450 3668–367810.1002/art.20594

Sano S Misiani R Bellavita P Fenili D Vicari O Marchesi D Sironi PL Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus N. Engl. J. Med. 1994330 751–75610.1056/NEJM199403173301104

Ferri C Marzo E Longombardo G Lombardini F La Civita L Vanacore R Interferon-alfa in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial Blood 199381 1132–1136

Casato M Agnello V Pucillo LP Knight GB Leoni M DelVecchio S Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection Blood 199790 3865–3873

Cacoub P Lidove O Maisonobe T Duhaut P Thibault V Ghillani P Interferon-alfa and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis Arthritis Rheum. 200246 3317–332610.1002/art.10699

Naarendorp M Kallemuchikkal U Nuovo GJ Gorevic PD Longterm efficacy of interferon-alfa for extrahepatic disease associated with hepatitis C virus infection J. Rheumatol. 200128 2466–2473

Saadoun D Resche-Rigon M Thibault V Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a longterm followup study Arthritis Rheum. 200654 3696–370610.1002/art.22168

Fain O Hamidou M Cacoub P Vasculitides associated with malignancies: analysis of sixty patients Arthritis Rheum. 200757 1473–148010.1002/art.23085

Hearth-Holmes M Zahradka S Baethge BA Leukocytoclastic vasculitis associated with hepatitis C Am. J. Med. 199190 6 765–76610.1016/S0002-9343(05)80071-3

Yazici Y Lockshin MD Paget S The vasculitides Hospital for Special Surgery Manual of Rheumatology and Outpatient Orthopedic Disorders 2006 5 Sage CA: Los Angeles, CA Lippincott

Calabrese LH The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis Arthritis Rheum. 199033 8 1108–1113

Cacoub P Poynard T Ghillani P Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment virus C Arthritis Rheum. 199942 2204–221210.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D

Osborne SF Stafford L Orr KG Paroxetine-associated psoriasis Am. J. Psychiatr. 2002 159 12 2113 10.1176/appi.ajp.159.12.2113

Brenner S Cabili S Wolf R Widespread erythematous scaly plaques in an adult. Psoriasiform eruption induced by quinidine Arch. Dermatol. 1993129 10 1331–133210.1001/archderm.129.10.1331

Sfikakis PP Iliopoulos A Elezoglou A Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction Arthritis Rheum. 200552 8 2513–251810.1002/art.21233

Collamer AN Guerrero KT Henning JS Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action Arthritis Rheum. 200859 7 996–100110.1002/art.23835

Taylor W Gladman D Marchesoni A Classification criteria for psoriatic arthritis: development of new criteria from a large international study Arthritis Rheum. 200654 8 2665–267310.1002/art.21972

Reich K Hüffmeier U König IR TNF polymorphisms in psoriasis: association of psoriatic arthritis with the promoter polymorphism TNF*-875 independent of the PSORS1 risk allele Arthritis Rheum. 200756 2056–206410.1002/art.22590

Cargill M Schrodi SJ Chang M A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes Am. J. Hum. Genet. 200780 273–29010.1086/511051

McHugh NJ Laurent MR Treadwell BL Psoriatic arthritis: clinical subgroups and histocompatibility antigens Ann. Rheum. Dis. 198746 13 84–88

Queiro R Gonzalez S Lopez-Larrea C HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis Arthritis Res. Ther. 2006 8 6 R185 10.1186/ar2097

Schröder JM Reich K Kabashima K Who is really in control of skin immunity under physiological circumstances—lymphocytes, dendritic cells or keratinocytes? Exp. Dermatol. 200615 913–929

Sano S Chan KS Carbajal S Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model Nat. Med. 200511 43–4910.1038/nm1162